Dr. Esteva on Trastuzumab Biosimilar in Breast Cancer

Dr. Jhaveri on the Use of Trastuzumab Biosimilars in Breast Cancer

Trastuzumab Deruxtecan for Patients With HER2 Metastatic Breast Cancer (mBC)

Trastuzumab Cardiotoxicity in mBC: When to Restart HER2 Therapy? Will Stopping Trastuzumab for 1 or 2 Administrations Impact the Patient Outcome?

Dr Fenton on Trastuzumab Deruxtecan Vs Trastuzumab Emtansine in HER2 Breast Cancer

Dr. Halmos on Trastuzumab Deruxtecan in NSCLC

Trastuzumab Deruxtecan in Patients With Metastatic Non-Small-Cell Lung Cancer (DESTINY-Lung01): Primary Results of the HER2 Overexpressing Cohorts From a Single-Arm, Phase 2 Trial